Therapeutic mechanisms of ginseng in coronary heart disease

Miao-Miao Tang1, Shu-Ting Zhao1, Ran-Qi Li1

  • 1Institute of Special Animal and Plant Sciences, Chinese Academy of Agricultural Sciences, Changchun, China.

Frontiers in Pharmacology
|October 19, 2023
PubMed

Insights

Ginseng, a traditional herb, shows potential in managing coronary heart disease (CHD) by improving cardiac function. It helps normalize blood sugar, lower blood pressure, and reduce oxidative stress, offering a natural therapy for CHD.

Area of Science:

  • Cardiovascular Medicine
  • Integrative and Complementary Medicine
  • Pharmacology

Background:

  • Coronary heart disease (CHD), a major manifestation of cardiovascular disease, stems from myocardial ischemia due to coronary atherosclerosis.
  • CHD prevalence is rising globally due to lifestyle and dietary shifts.
  • Ginseng, a long-established Chinese medicinal herb, has a history of use in food and traditional medicine.

Purpose of the Study:

  • To review the mechanisms by which ginseng alleviates coronary heart disease (CHD).
  • To provide a reference for the clinical application of ginseng as an alternative CHD therapy.

Main Methods:

  • This is a review article.
  • It synthesizes existing research on ginseng's effects on cardiovascular health.
  • Focuses on mechanisms of action relevant to CHD.

Main Results:

  • Ginseng has demonstrated benefits for cardiac function in vivo.
  • Observed effects include normalization of blood glucose, decreased blood pressure, reduced oxidative stress, and improved lipid profiles.
  • Ginseng also mitigates platelet aggregation.

Conclusions:

  • Ginseng exhibits multiple mechanisms beneficial for alleviating coronary heart disease (CHD).
  • Further clinical development of ginseng as an alternative therapy for CHD is warranted.
  • Ginseng represents a promising natural intervention for cardiovascular health.

Related Concept Videos

Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
608
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
598
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
438
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
540
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
9